BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15258224)

  • 1. Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson's disease.
    Fregni F; Santos CM; Myczkowski ML; Rigolino R; Gallucci-Neto J; Barbosa ER; Valente KD; Pascual-Leone A; Marcolin MA
    J Neurol Neurosurg Psychiatry; 2004 Aug; 75(8):1171-4. PubMed ID: 15258224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: a randomized, double-blind, placebo-controlled study.
    Pal E; Nagy F; Aschermann Z; Balazs E; Kovacs N
    Mov Disord; 2010 Oct; 25(14):2311-7. PubMed ID: 20740485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of high-frequency repetitive transcranial magnetic stimulation on major depressive disorder in patients with Parkinson's disease.
    Shin HW; Youn YC; Chung SJ; Sohn YH
    J Neurol; 2016 Jul; 263(7):1442-8. PubMed ID: 27178002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. rTMS treatment for depression in Parkinson's disease increases BOLD responses in the left prefrontal cortex.
    Cardoso EF; Fregni F; Martins Maia F; Boggio PS; Luis Myczkowski M; Coracini K; Lopes Vieira A; Melo LM; Sato JR; Antonio Marcolin M; Rigonatti SP; Cruz AC; Reis Barbosa E; Amaro E
    Int J Neuropsychopharmacol; 2008 Mar; 11(2):173-83. PubMed ID: 17708780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 0.2-Hz repetitive transcranial magnetic stimulation has no add-on effects as compared to a realistic sham stimulation in Parkinson's disease.
    Okabe S; Ugawa Y; Kanazawa I;
    Mov Disord; 2003 Apr; 18(4):382-8. PubMed ID: 12671943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Frequency Repetitive Transcranial Magnetic Stimulation Can Improve Depression in Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Study.
    Makkos A; Pál E; Aschermann Z; Janszky J; Balázs É; Takács K; Karádi K; Komoly S; Kovács N
    Neuropsychobiology; 2016; 73(3):169-77. PubMed ID: 27093063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repetitive transcranial magnetic stimulation (rTMS) for the treatment of depression in Parkinson disease: a meta-analysis of randomized controlled clinical trials.
    Xie CL; Chen J; Wang XD; Pan JL; Zhou Y; Lin SY; Xue XD; Wang WW
    Neurol Sci; 2015 Oct; 36(10):1751-61. PubMed ID: 26209930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic efficacy of bilateral prefrontal slow repetitive transcranial magnetic stimulation in depressed patients with Parkinson's disease: an open study.
    Dragasevic N; Potrebić A; Damjanović A; Stefanova E; Kostić VS
    Mov Disord; 2002 May; 17(3):528-32. PubMed ID: 12112202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-frequency repetitive transcranial magnetic stimulation over the primary foot motor area in Parkinson's disease.
    Maruo T; Hosomi K; Shimokawa T; Kishima H; Oshino S; Morris S; Kageyama Y; Yokoe M; Yoshimine T; Saitoh Y
    Brain Stimul; 2013 Nov; 6(6):884-91. PubMed ID: 23769414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of slow repetitive transcranial magnetic stimulation on depression in patients with Parkinson 's disease].
    Potrebić A; Dragasević N; Svetel M; Kostić VS
    Srp Arh Celok Lek; 2001; 129(9-10):235-8. PubMed ID: 11928600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of slow repetitive transcranial magnetic stimulation on depression in patients with Parkinson disease].
    Potrebić A; Dragasević N; Svetel M; Kostić VS
    Srp Arh Celok Lek; 2001; 129(1-2):1-4. PubMed ID: 11534277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repetitive transcranial magnetic stimulation of the primary motor cortex in the treatment of motor signs in Parkinson's disease: A quantitative review of the literature.
    Zanjani A; Zakzanis KK; Daskalakis ZJ; Chen R
    Mov Disord; 2015 May; 30(6):750-8. PubMed ID: 25786995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of repetitive transcranial magnetic stimulation on cognitive impairment in Parkinson's disease with dementia: Pilot study.
    Khedr EM; Mohamed KO; Ali AM; Hasan AM
    Restor Neurol Neurosci; 2020; 38(1):55-66. PubMed ID: 31815705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supplementary motor area stimulation for Parkinson disease: a randomized controlled study.
    Shirota Y; Ohtsu H; Hamada M; Enomoto H; Ugawa Y;
    Neurology; 2013 Apr; 80(15):1400-5. PubMed ID: 23516319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression.
    Boggio PS; Fregni F; Bermpohl F; Mansur CG; Rosa M; Rumi DO; Barbosa ER; Odebrecht Rosa M; Pascual-Leone A; Rigonatti SP; Marcolin MA; Araujo Silva MT
    Mov Disord; 2005 Sep; 20(9):1178-84. PubMed ID: 15895421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine does not impair motor function in patients with Parkinson's disease: correlation between mood and motor functions with plasma concentrations of fluoxetine/norfluoxetine.
    Kostić V; Dzoljić E; Todorović Z; Mijajlović M; Svetel M; Stefanova E; Dragasević N; Petrović I; Milosević M; Kovacević I; Miljković B; Pokrajac M; Prostran M
    Vojnosanit Pregl; 2012 Dec; 69(12):1067-75. PubMed ID: 23424961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and neurophysiological effects of dual-target high-frequency rTMS over the primary motor and prefrontal cortex in Parkinson's disease].
    Aftanas LI; Brack IV; Kulikova KI; Filimonova EA; Dzemidovich SS; Piradov MA; Suponeva NA; Poidasheva AG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(5):29-36. PubMed ID: 32621465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
    Bares M; Kopecek M; Novak T; Stopkova P; Sos P; Kozeny J; Brunovsky M; Höschl C
    J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open study of repetitive transcranial magnetic stimulation in treatment-resistant depression with Parkinson's disease.
    Epstein CM; Evatt ML; Funk A; Girard-Siqueira L; Lupei N; Slaughter L; Athar S; Green J; McDonald W; DeLong MR
    Clin Neurophysiol; 2007 Oct; 118(10):2189-94. PubMed ID: 17714987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.